Cargando…
Influence of Charge, Hydrophobicity, and Size on Vitreous Pharmacokinetics of Large Molecules
PURPOSE: Development of therapeutics for retinal disease with improved durability is hampered by inadequate understanding of pharmacokinetic (PK) drivers following intravitreal injection. Previous work shows that hydrodynamic radius is correlated with vitreal half-life over the range of 3 to 7 nm, a...
Autores principales: | Crowell, Susan R., Wang, Kathryn, Famili, Amin, Shatz, Whitney, Loyet, Kelly M., Chang, Vincent, Liu, Yanqiu, Prabhu, Saileta, Kamath, Amrita V., Kelley, Robert F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827426/ https://www.ncbi.nlm.nih.gov/pubmed/31695962 http://dx.doi.org/10.1167/tvst.8.6.1 |
Ejemplares similares
-
Effect of molecular size on interstitial pharmacokinetics and tissue catabolism of antibodies
por: Rafidi, Hanine, et al.
Publicado: (2022) -
Pharmacokinetic and Pharmacodynamic Considerations in the Design of Therapeutic Antibodies
por: Leipold, Douglas, et al.
Publicado: (2018) -
Identification and characterization of an octameric PEG-protein conjugate system for intravitreal long-acting delivery to the back of the eye
por: Shatz, Whitney, et al.
Publicado: (2019) -
Antibody Format and Serum Disposition Govern Ocular Pharmacokinetics of Intravenously Administered Protein Therapeutics
por: Shivva, Vittal, et al.
Publicado: (2021) -
Prediction of Human Pharmacokinetics of Antibody–Drug Conjugates From Nonclinical Data
por: Li, Chunze, et al.
Publicado: (2019)